This journal focuses on research related to haemophilia and von Willebrand disease. It covers topics such as novel therapeutic targets and treatments, including TFPI-neutralizing antibodies and gene therapy. The scope also includes the economic burden of these conditions, patient-reported outcomes, adherence to treatment, and the management of thrombotic events in patients with von Willebrand disease. Additionally, the journal addresses the complexities of factor replacement therapy, including pharmacokinetic variability and assay accuracy, as well as the role of nurses in patient care pathways.
Hemophilia Treatment and ResearchPlatelet Disorders and TreatmentsBlood Coagulation and Thrombosis MechanismsCoagulation, Bradykinin, Polyphosphates, and AngioedemaHemostasis and retained surgical itemsMyeloproliferative Neoplasms: Diagnosis and TreatmentBlood transfusion and managementChronic Myeloid Leukemia TreatmentsCancer-related gene regulationBlood groups and transfusion